Abortions Have Increased, Even in States With Bans, Report Finds
By Robin Foster HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- A new report shows the number of women getting abortions in the United...
FDA Appoints New Head of Medical Devices
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration announced Tuesday that it has appointed Dr....
AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir
AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
Findings show higher risk for nonclearing vitreous hemorrhage, retinal tear and detachment, anterior vitrectomy, and glaucoma surgery
Urban Green Space May Protect Against Heat-Related Health Risks
Additional benefit seen for mental health and well-being
Poll Finds Most Americans Stressed Over Election, Future of Nation
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- Most Americans say they’re stressed out over the future of the United States...
One Dead, 10 Hospitalized in E. Coli Outbreak Linked to McDonald’s Quarter Pounders
By Robin Foster HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- An E. coli outbreak tied to McDonald's Quarter Pounders has sickened 49 people...
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders
Highest rates of SCD seen for patients with schizophrenic disease; 10-year excess loss of life expected for 18-year-olds with psychiatric disorder
FDA Approves Vyalev for Advanced Parkinson Disease
Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for treatment of motor fluctuations
